Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZEP-3 Ointment for Cold Sores
NCT02483182Phase 2Completed
- Sponsor
- Shulov Innovative Science
- Start
- Sep 2015
- Primary completion
- Jun 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ZEP-3 in herpes labialis, sponsored by Shulov Innovative Science. Started Sep 2015; status: completed.
02
Drugs
ZEP-3
03
Conditions
herpes labialis
Beyond the preview
Go deeper on NCT02483182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02483182.